Myung Ho Jeong

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Echocardiographic Epicardial Fat Thickness and Coronary Artery Disease

Jin‐Won Jeong, Myung Ho Jeong, Kyeong Ho Yun et al. · Circulation Journal · 2007 · 383 citations · Full text

Medicine, Cardiology, Clinical Sciences +11

Extent, Location, and Clinical Significance of Non–Infarct-Related Coronary Artery Disease Among Patients With ST-Elevation Myocardial Infarction

Duk‐Woo Park, Robert M. Clare, Phillip J. Schulte et al. · JAMA · 2014 · 371 citations

Medicine, Cardiology, Internal Medicine +16

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · The Lancet · 2018 · 366 citations

Medicine, Cardiology, Pharmacotherapy +17